Targeting proteasome composition reprograms tumor-intrinsic inflammation through selective degradation of STAT1
Merav D. Shmueli, Yongfeng Tao, Ekampreet Singh, Matthias P. Kramer, Anat Abramov, Tuval Aizik, Daoud Sheban, Arseniy A. Lobov, Karin Goldberg, Angham Ibraheem, Ronen Shteinvil, Aaron Javitt, Yishai Levin, Michael A. Schafroth, Daisuke Ogasawara, , Yifat Merbl
This study identifies a small molecule targeting PSME4, which stabilizes STAT1 and reprograms tumor inflammation, suppressing tumor growth by altering cytokine signaling.
bioRxiv · Oct 16, 2026 · PreprintCancer Biology